Severe COVID-19 Associated With Functional, Radiologic Abnormalities at 4 Months
After a follow-up period of 4 months, severe/critical COVID-19 was associated with significant lung function changes and radiologic abnormalities in patients.
COVID19
Pfizer and BioNTech mRNA COVID-19 Vaccine Conferred 95% Protection
Pfizer and BioNTech release safety and efficacy data from phase 2/3 trials for their COVID-19 mRNA vaccine.
COVID-19 Vaccine Recommended for All Americans Over 65
COVID-19 vaccine recommended for every American older than 65 years, in an attempt to speed up the nation’s vaccine rollout.
Life Expectancy Reduced for Black, Latino Patients Because of COVID-19
The COVID-19 pandemic has had a considerable impact on life expectancy in the United States, especially among Black and Latino populations.
Previous COVID-19 Infection May Confer Immunity for 5 Months or Longer
Immunity against the new coronavirus can last for at least five months in most people who have been infected
Smokers More Likely to Report Symptoms Suggestive of COVID-19
Current smokers are more likely to report symptoms suggesting a diagnosis of COVID-19.
Phase 3 Study Evaluating Ravulizumab for COVID-19 Paused
The open-label, controlled study enrolled adults hospitalized with COVID-19 and severe pneumonia, acute lung injury or acute respiratory distress syndrome.
Ad26.COV2-S Vaccine Seems Safe, Immunogenic for SARS-CoV-2
Ad26.COV2.S with a recombinant, replication-incompetent Ad26 vector encoding a full-length and stabilized SARS-CoV-2 spike protein is safe and immunogenic.
FDA Fast Tracks Brilacidin for COVID-19 Treatment
The Food and Drug Administration has granted Fast Track designation to brilacidin for the treatment of COVID-19.
11.1 Anaphylaxis Cases Per 1 Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
Researchers determined there were 21 cases of anaphylaxis after receipt of the first dose of the Pfizer-BioNTech COVID-19 vaccine in the United States.
-
Loading...
-
Loading...
Next post in Lung Infection
